Rite Aid Corp. (RAD)
Management at Rite Aid Corporation (RAD - Analyst Report) was executing a turnaround strategy centered on increasing the profitability of the existing store base. However, the acquisition of Brooks Eckerd prior to a convincing turnaround in profitability has increased the debt burden and interest expense.
Moreover, Wal-Mart's foray into the retail generic drug market has pressured the company's pharmacy margin. Given the weakness of front-end sales and management's continual lowering of EPS guidance (for larger net losses), the stock's rating remains Underperform.
Rite Aid Corp. (RAD) : FULL ANALYST REPORT
|
Read the full analyst report on RAD

Sponsored Links 
Loading Stories...
-1.67
0.64